Biosimulation Market Grows At 17%, Supported By The Surge In Healthcare Expenditure

Biosimulation Market Report 2021: COVID-19 Implications And Growth

Biosimulation Global Market Report 2021: COVID-19 Implications And Growth

The Business Research Company’s Biosimulation Global Market Report 2021 – COVID-19 Implications And Growth

LONDON, GREATER LONDON, UK, October 6, 2021 / — The surge in healthcare expenditure worldwide is expected to support the biosimulation market over the forecast period. Increasing healthcare spending is likely to provide more expenditure on the development of drugs, which in turn will drive the revenues generated from the biosimulation solutions. Biosimulation software is currently being used in the development of drugs to mimic diseases. With the help of the biosimulation software, virtual clinical trials can be conducted for new developing pharmaceutical drugs using computers running disease simulations. Therefore, the surge in healthcare expenditure drives the growth of the biosimulation market.

The global biosimulation market size is expected to grow from $2.71 billion in 2020 to $3.17 billion in 2021 at a compound annual growth rate (CAGR) of 17.1%. The change in growth trend of the biosimulation market is mainly due to the companies stabilizing their output after catering to the demand that grew exponentially during the COVID-19 pandemic in 2020. The biosimulation market is expected to reach $5.29 billion in 2025 at a CAGR of 13.7%.

Read More On The Global Biosimulation Market Report:

Major players covered in the global biosimulation industry are Certara, Dassault Systèmes, Schrödinger Inc., Simulations Plus Inc., Rhenovia Pharma, Insilico Biotechnology AG, Genedata AG, Entelos Inc., Physiomics plc, Rosa & Co. LLC., In silico biosciences Inc., INOSIM Software, LeadInvent Technologies, Nuventra Pharma, and Archimedes.

TBRC’s global biosimulation market report is segmented by product into software, services, by application into drug development, drug discovery, others, by end user into pharmaceutical and biotechnology companies, contract research organizations (CROs), regulatory authorities, academic research institutions, others.

Biosimulation Global Market Report 2021 – By Product (Software, Services), By Application (Drug Development, Drug Discovery), By End User (Pharmaceutical And Biotechnology Companies, Contract Research Organizations (CROs), Regulatory Authorities, Academic Research Institutions), COVID-19 Implications And Growth is one of a series of new reports from The Business Research Company that provides biosimulation market overview, forecast biosimulation market size and growth for the whole market, biosimulation market segments, and geographies, biosimulation market trends, biosimulation market drivers, restraints, leading competitors’ revenues, profiles, and market shares.

Request For A Sample Of The Global Biosimulation Market Report:

Here Is A List Of Similar Reports By The Business Research Company:

Bioinformatics Global Market Report 2021 – By Products and Services (Knowledge Management Tools, Data Analysis Platforms, Services), By Application (Metabolomics, Molecular Phylogenetics, Transcriptomics, Proteomics, Cheminformatics, Genomics), By End Users (Pharmaceutics, Animal Study, Agriculture, Forensic Science), COVID-19 Growth And Change

Automated Breach And Attack Simulation Global Market Report 2021 – By Component (Services, Platforms/ Tools), By Deployment Mode (On-Premises, Cloud), By End User (Enterprises And Data Centers, Managed Service Providers), By Application (Configuration Management, Patch Management, Threat Intelligence, Team Assessment), COVID-19 Growth And Change

Database Software Market 2021 – By Product Type (Database Maintenance Management, Database Operation Management), By End User (BFSI, IT & Telecom, Media & Entertainment, Healthcare, Others), By Type Of Deployment (Cloud, On-Premise), And By Region, Opportunities And Strategies – Global Forecast To 2030

Interested to know more about The Business Research Company?

The Business Research Company is a market research and intelligence firm that excels in company, market, and consumer research. It has over 200 research professionals at its offices in India, the UK and the US, as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.

Read more about us at

Or get a quick glimpse of our services here:

Call us now for personal assistance with your purchase:
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293

The Business Research Company
Follow us on LinkedIn:
Follow us on Twitter:
Check out our Blog:

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
Visit us on social media:

Leave a Reply

Your email address will not be published.